FDA: Page 2
-
Intuitive Surgical recalls stapler reloads over issue linked to patient death
The recall follows reports of incomplete staple lines in procedures using the company’s da Vinci surgical robots.
By Nick Paul Taylor • March 19, 2026 -
JenaValve snags FDA approval in aortic regurgitation
The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.
By Susan Kelly • March 18, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
FDA to unify agency’s ‘fragmented’ safety surveillance system
Combining the disparate databases used to detect potential issues with drugs, vaccines and other products into a single dashboard will enhance their utility and cut costs, the agency said.
By Kristin Jensen • March 12, 2026 -
Advita Ortho receives warning letter related to shoulder system
Advita Ortho was formed after orthopedic implant maker Exactech sold its assets in bankruptcy.
By Elise Reuter • March 12, 2026 -
Medtech industry calls for FDA staffing transparency in MDUFA talks
Stakeholders also discussed changing international user fees and the FDA’s spending trigger for the program.
By Elise Reuter • March 5, 2026 -
Abbott wins FDA approval for updated heart failure monitoring device
The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.
By Nick Paul Taylor • March 2, 2026 -
FDA warns Beta Bionics on unreported complaints, insulin pump changes
The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.
By Elise Reuter • Feb. 26, 2026 -
FDA posts early alert for safety issue with Impella heart pump devices
The cassettes have an increased risk of purge leaks that can lead to the loss of hemodynamic support.
By Nick Paul Taylor • Feb. 26, 2026 -
Medline addresses bed fire risk linked to death
The FDA said hand pendants and cords may overheat, causing the devices to spark, burn, melt, smoke and catch fire.
By Nick Paul Taylor • Feb. 18, 2026 -
HHS elevates officials into Kennedy’s inner circle in advance of midterms
The HHS secretary has four new senior advisors to help him “move faster and go further” on his Make America Healthy Again agenda. The appointments preempt the GOP’s midterm messaging push.
By Rebecca Pifer Parduhn • Feb. 13, 2026 -
Novocure wins FDA approval to treat pancreatic cancer with electric fields
Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.
By Nick Paul Taylor • Feb. 13, 2026 -
FDA breakthrough program starts FY2026 at steady pace
Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.
By Nick Paul Taylor • Feb. 9, 2026 -
J&J recalls coil systems used in aneurysm treatment
Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries and one death.
By Susan Kelly • Feb. 6, 2026 -
Medtronic wins expanded FDA label for 780G insulin pump
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
By Nick Paul Taylor • Feb. 5, 2026 -
J&J corrects Impella heart pumps over issue linked to 22 serious injuries
The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.
By Nick Paul Taylor • Feb. 4, 2026 -
Beta Bionics receives FDA warning letter
The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.
By Elise Reuter • Feb. 2, 2026 -
Grail files for FDA approval of multi-cancer early detection test
Premarket approval could help the company secure coverage from commercial payers and Medicare.
By Nick Paul Taylor • Feb. 2, 2026 -
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.
By Ricky Zipp • Jan. 29, 2026 -
CDRH on track for review timelines despite staff cuts
The Center for Devices and Radiological Health said it is on track to meet review times specified by user fee agreements, despite “resource challenges.”
By Elise Reuter • Jan. 29, 2026 -
FDA guidance eases wearables oversight. But experts have questions about what’s next.
Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.
By Elise Reuter • Jan. 27, 2026 -
Integra recalls wound and burn devices amid reports of serious injuries
Packaging failures could lead to breaches in the sterile barrier and patient infections.
By Nick Paul Taylor • Jan. 23, 2026 -
AdvaMed leaders on tariffs, MDUFA and wearables
AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.
By Elise Reuter • Jan. 22, 2026 -
Boston Scientific recalls stent over issue linked to 3 deaths
The company said the deaths were associated with off-label or investigational use of the device.
By Nick Paul Taylor • Jan. 20, 2026 -
Deep Dive
5 topics to watch as MDUFA negotiations restart
The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.
By Elise Reuter • Jan. 14, 2026 -
FDA exempts more wearable, AI features from oversight
In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight.
By Elise Reuter • Jan. 8, 2026